Brentuximab vedotin and Von Willebrand factor recombinant
Determining the interaction of Brentuximab vedotin and Von Willebrand factor recombinant and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: brentuximab
Brand name: Adcetris
Synonyms: Brentuximab Vedotin
Generic Name: von willebrand factor
Brand name: Vonvendi, Wilfactin
Synonyms: Von Willebrand factor (recombinant), von Willebrand Factor (Recombinant)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Brentuximab vedotin-Von willebrand factor recombinant Intravenous
- Brentuximab vedotin-Vonvendi
- Brentuximab vedotin-Vopac
- Brentuximab vedotin-Vopac MDS
- Brentuximab vedotin-Vorapaxar
- Brentuximab vedotin-Vorapaxar Sulfate
- Von Willebrand factor recombinant-Breo Ellipta
- Von Willebrand factor recombinant-Brethine
- Von Willebrand factor recombinant-Brethine Subcutaneous
- Von Willebrand factor recombinant-Bretylium
- Von Willebrand factor recombinant-Bretylium Injection
- Von Willebrand factor recombinant-Brevibloc